Allianz Asset Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,100
| Closed | -$365K | – | 1585 |
|
|
2022
Q3 | $365K | Sell |
24,100
-145,275
| -86% | -$2.2M | ﹤0.01% | 1354 |
|
|
2022
Q2 | $1.27M | Buy |
169,375
+15,170
| +10% | +$114K | ﹤0.01% | 1423 |
|
|
2022
Q1 | $1.4M | Buy |
154,205
+45,380
| +42% | +$413K | ﹤0.01% | 1468 |
|
|
2021
Q4 | $764K | Sell |
108,825
-27,400
| -20% | -$192K | ﹤0.01% | 1688 |
|
|
2021
Q3 | $1.55M | Hold |
136,225
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q2 | $2.18M | Sell |
136,225
-16,355
| -11% | -$262K | ﹤0.01% | 1283 |
|
|
2021
Q1 | $2.73M | Hold |
152,580
| – | – | ﹤0.01% | 1174 |
|
|
2020
Q4 | $2.06M | Hold |
152,580
| – | – | ﹤0.01% | 1288 |
|
|
2020
Q3 | $1.8M | Buy |
152,580
+10,950
| +8% | +$129K | ﹤0.01% | 1281 |
|
|
2020
Q2 | $2.09M | Buy |
141,630
+71,375
| +102% | +$1.05M | ﹤0.01% | 1249 |
|
|
2020
Q1 | $948K | Buy |
70,255
+25,134
| +56% | +$339K | ﹤0.01% | 1466 |
|
|
2019
Q4 | $1.09M | Buy |
45,121
+1,473
| +3% | +$35.6K | ﹤0.01% | 1678 |
|
|
2019
Q3 | $853K | Sell |
43,648
-1,090
| -2% | -$21.3K | ﹤0.01% | 1733 |
|
|
2019
Q2 | $1.32M | Sell |
44,738
-16,747
| -27% | -$495K | ﹤0.01% | 1675 |
|
|
2019
Q1 | $2.92M | Buy |
61,485
+18,127
| +42% | +$861K | ﹤0.01% | 1433 |
|
|
2018
Q4 | $1.57M | Buy |
+43,358
| New | +$1.57M | ﹤0.01% | 1535 |
|